Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
On December 31, 2015, Bitzio acquired sole ownership of Viridis Capital LLC (“Viridis”) from FLUX Carbon Corporation (“FCC”), an entity owned by Kevin Kreisler. In consideration for the transfer of Viridis, Bitzio issued to FCC 800,000 shares of Bitzio’s Series F Preferred Stock. The principal asset owned by Viridis at that time was 800,115 shares of Series D Preferred Stock issued by GreenShift Corporation (“GreenShift”), a Delaware corporation.
On the same date, Bitzio issued to EXO Opportunity Fund LLC (“EXO”) 200,000 shares of Series E Preferred Stock, and received in return 187,029 shares of GreenShift Series D Preferred Stock. One of the two members of EXO is an entity owned by the father of Kevin Kreisler, the Chief Executive Officer of GreenShift.
Subsequently, on that same date, Bitzio surrendered 987,144 Series D shares and paid $2,500,000 in cash to GreenShift in exchange for 800,000 shares of GreenShift’s Series G Preferred Stock, corresponding to an 80% equity interest in GreenShift.
GreenShift Corporation (OTC Pink: GERS) develops and commercializes clean technologies that facilitate the more efficient use of natural resources. GreenShift markets primarily to the U.S. ethanol industry, where it offers technologies that improve the profitability of licensed ethanol producers. GreenShift generates revenue by licensing its technologies to ethanol producers, and by providing its licensees with related services.
https://www.sec.gov/Archives/edgar/data/1347078/000149315216006935/form8-k.htm
Acasti Pharma To Present at Biotech Showcase Conference On Jan 10
Laval, Québec, CANADA – January 2, 2018 – Acasti Pharma Inc. (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre® (omega-3 phospholipid) for the treatment of severe hypertriglyceridemia, today announced that Jan D’Alvise, the company’s president and chief executive officer will present at Biotech Showcase Conference on Wednesday, January 10 at 11:00 a.m. PT in Yosemite - A of the Ballroom Level. The conference will take place at the Hilton San Francisco Union Square.
A live audio webcast of the presentation will be available under the “News & Investors” section of Acasti's website at www.acastipharma.com. A replay of the presentation will be available for 60 days following the event.
http://www.acastipharma.com/wp-content/uploads/Acasti-Presents-at-Biotech-Showcase.FINAL_.pdf
Last we heard it was around 7.5 billion
Let's go $BTZO!!!!!!
All it’s going to take is a single PR stating that they are going to begin filing again and mention ther $GERS settlement. Then it’s off to the races. Go $BTZO!!!!!
Right. Between packerup, Hubert Blanchette, and Marilu Brassington there is almost half a billion. Hubert and Marilu are probably doing their best to convince Kreisler to release some $BTZO favorable news, so they can cash in. Go $BTZO!!!!
That is my thought. Everyone knows KK is one of the kings of the Pinkies. He’s not going to know what do do with all of that money. $BTZO
$BTZO doesn’t have an industry, or earnings per share. They don’t have any revenue. This money would be the only asset that puts them in the black. P/E ratios are for legitimate companies. So there is no telling what the value will be.
If $BTZO owns 80% of $GERS, 80% of $200mm is 160mm. If the OS is roughly 8B, that puts us at $.02. That’s straight math, but we all know things are crooked in the OTC. Does anyone know if KK has ever been involved with a company with this size of liquidity?
That would be amazing. If this comes through, I’ll fly out to CA and give Marilu a big ole hug. Merry Christmas.
Good one., Mr. Bug. I think we know more about $BTZO than we care to know. If this settlement is the amount or close to the amount that has been speculated, we are bound to move. Happy Holidays to everyone. We’re all in the same boat, so being negative to each other doesn’t do anything helpful.
$ACST just needs to provide the required documents for the contract, then it's boom time.
What was the A/S, O/S for that play when it was at .0002?
The A/S is 10B.
10,000,000,000@.0001 COMMON STOCK 25,000,000@.001 PREFERRED STOCK Previous Stock Value: Par Value Shares: 4,200,000,000 Value: $ 0.0001 Par Value Shares: 25,000,000 Value: $ 0.001 No Par Value Shares: 0 ----------------------------------------------------------------- Total Authorized Capital: $ 445,000.00 New Stock Value: Par Value Shares: 10,000,000,000 Value: $ 0.0001 Par Value Shares: 25,000,000 Value: $ 0.001 No Par Value Shares: 0 ----------------------------------------------------------------- Total Authorized Capital: $ 1,025,000.00
Seems like it. Let the party begin!!!! $ACST!!
Fantastic day. I've been accumulating for the last year. My avg. is $1.42. Pretty good payday!!!!! $ACST
You better buy on the dip!!! $ACST
Beautiful!! $ACST
About 5 mil sold at .0002 today
No one else is giving up their 1’s. Go $BTZO!!!!
187 mm on the ask @.0002
41mm on the bid at 0001 for awhile now. $BTZO!!!!
Agreed. This is looking promising agaim.
Acasti Pharma Announces Dariush Mozaffarian, M.D., Dr.P.H. Principal Investigator for CaPre Phase 3 Development Program
http://www.acastipharma.com/wp-content/uploads/Acasti-Mozaffarian-Press-Release.3November2017-FINAL.pdf
Let’s cross our fingers, Mr. Bug. We’ve been here a loooooong time. It will be nice to see green for a change.$BTZO!!!!!!!
I’m still broke. $BTZO !!!!!!!!
Acasti reports 1Q loss
Acasti Pharma Reports First Quarter FY 2018 Financial Results
https://finance.yahoo.com/news/acasti-pharma-reports-first-quarter-213000962.html
Acasti Pharma Inc (ACST) Sees RMI Trending Upward
https://stockdailyreview.com/acasti-pharma-inc-acst-sees-rmi-trending-upward-2/
Acasti Pharma Announces Issuance of Common Shares in Payment of Outstanding Interest Under Debentures
http://www.marketwired.com/press-release/acasti-pharma-announces-issuance-common-shares-payment-outstanding-interest-under-debentures-tsx-venture-acst-2228067.htm
Kreisler started a new scam last year. PC Platinum Travel. Along with Jeremy Monte
http://affiliates.wwpa.com/post/Suspicious-Global-Platinum-Services-globalplatinumservicescom-Monte-Jeremy.aspx
https://nvsilverflume.gov/businessSearch
CORRECTION: Acasti Pharma Grants Stock Options
http://www.acastipharma.com/wp-content/uploads/Acasti-PR_Stock-Options_Correction-FINAL.pdf
Acasti Pharma Grants Stock Options
http://www.acastipharma.com/wp-content/uploads/Acasti-PR_Stock-Options_2017-06-14__FINAL.pdf
Acasti and CordenPharma look to continuous production for Omega-3 drug.
http://www.in-pharmatechnologist.com/Processing/Acasti-and-CordenPharma-look-to-continuous-production-for-omega-3-drug?utm_source=copyright&utm_medium=OnSite&utm_campaign=copyright